Posted in

Coldrif Syrup Tragedy: Owner Arrested Amidst Rising Toll

•Posted inMedical Updates
Indian doctor preparing for PLAB exam to start a career in the UK healthcare system

In a significant development concerning the tragic coldrif cough syrup deaths, Sresan Pharma owner Ranganathan has been sent to 10-day police custody by a Parasia court on Friday. This action follows the deaths of 20 children, primarily in Madhya Pradesh, allegedly linked to the consumption of Coldrif cough syrup. Authorities are taking stringent measures to address the pharmaceutical safety lapses that led to this unfortunate incident.

Understanding the Coldrif Cough Syrup Deaths

The owner of Sresan Pharma, Ranganathan, was arrested by a Special Investigation Team (SIT) from Chhindwara in Chennai. He was subsequently brought to Chhindwara for legal proceedings. Madhya Pradesh Deputy Chief Minister and Health Minister Rajendra Shukla confirmed that 20 children in the state have died after consuming the Coldrif cough syrup, with five still receiving treatment. Of these fatalities, 17 children were from Chhindwara district, two from Betul, and one from Pandhurna.

The cough syrup, Coldrif, was found to be contaminated with diethylene glycol (DEG), a toxic industrial solvent that can be fatal even in small quantities. This contamination has raised serious concerns about quality control in pharmaceutical manufacturing. In response to these actions, the Chhindwara Chemist Association has declared an indefinite strike, protesting the sealing of several medical stores in the district.

Regulatory Response to Prevent Future Cough Syrup Deaths

The Drugs Controller General of India (DCGI), Dr. Rajeev Singh Raghuvanshi, has issued a crucial directive to all States and Union Territories. This directive emphasizes strict compliance with the Drugs Rules, 1945, particularly for the rigorous testing of raw materials and finished pharmaceutical formulations. Dr. Raghuvanshi highlighted the critical importance of testing new materials, including excipients, before their use in manufacturing pharmaceutical products. This measure aims to prevent similar tragedies and bolster the quality and safety of medicines. For professionals looking to enhance their understanding of drug safety and regulatory affairs, consider exploring courses related to safe prescribing and pharmaceutical quality control.

Frequently Asked Questions

Q1: What is the primary reason for the Coldrife cough syrup deaths?

The deaths are primarily linked to the Coldrif cough syrup being contaminated with diethylene glycol (DEG), a highly toxic industrial solvent.

Q2: How many children have died due to the contaminated cough syrup?

As per official reports, 20 children have died in Madhya Pradesh, with 17 from Chhindwara district, two from Betul, and one from Pandhurna. Understanding pediatric health and the specific needs of children is crucial in such cases. For those interested in this field, the Certification Course In Paediatrics offers valuable insights.

Q3: What actions are being taken by regulatory bodies?

The Drugs Controller General of India (DCGI) has mandated strict compliance with drug testing rules for raw materials and finished products, to enhance pharmaceutical safety and prevent future incidents. This focus on regulatory compliance and quality assurance is paramount in the pharmaceutical industry. Professionals seeking to deepen their knowledge in this area might find the Certification Course In Safe Prescribing beneficial.

References

  1. Coldrif cough syrup deaths: Sresan Pharma owner Ranganathan sent to 10-daypolice custody – ETHealthworld.
  2. Owner of Sresan Pharma arrested over death of 20 children linked to Coldrif syrup; to be brought to Chhindwara soon – DD News.
  3. Police arrest owner of drug company linked to deaths of 21 children in India – CBS News.
  4. Cough Syrup Deaths in India: Understanding the Contamination Crisis and Regulatory Response – Vision IAS.
  5. Coldrif cough syrup maker shut permanently over child deaths, owner arrested – India Today.
  6. Who is Sresan Pharma owner G Ranganathan arrested in Coldrif cough syrup case?
  7. India probes possible cough syrup link to deaths of at least nine children – Al Jazeera.
  8. Centre orders strict drug testing after toxic cough syrup kills 14 children | Today News – Mint.
  9. Owner Of Pharma Company Arrested In Child Deaths Linked to Coldrif Syrup – NDTV.
  10. Cough syrup deaths: Drug Controller asks states, UTs to ensure strict testing of medicine; WHO seeks clarification | Today News – Mint.
  11. MP cough syrup tragedy: Sresan Pharma’s Ranganathan taken to Parasia court – tennews.in.
  12. WHO seeks Indian clarification over export of ‘Coldrif’ syrup – The Economic Times.
  13. Cough syrup deaths: Tamil Nadu’s Sresan Pharma owner brought to M.P.’s Chhindwara, sent to 10-day police custody – The Hindu.
  14. After 20 kids die, DCGI cracks down on cough syrup quality failures – Hindustan Times.
  15. After Cough Syrup Deaths, CDSCO Tightens Oversight on Drug Testing Compliance.
  16. India’s Drug Regulator Responds To Child Fatalities With New Cough Syrup Testing Guidelines – Oneindia.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.